Bio Rad Laboratories Inc (NYSE:BIO)
| 403.92 Delayed Data As of Nov 25 |  -0.02 / -0.00%Today’s Change | 344.63 Today|||52-Week Range 771.69 | -46.54% Year-to-Date |
Latest BIO News | Press Releases
No recent news for Bio Rad Laboratories Inc.
Today’s Trading
| Previous close | 403.94 |
| Today’s open | 404.04 |
| Day’s range | 401.82 - 406.70 |
| Volume | 54,007 |
| Average volume (3 months) | 204,678 |
| Market cap | $10.0B |
Data as of 1:00pm ET, 11/25/2022
Growth & Valuation
| Earnings growth (last year) | +11.31% |
| Earnings growth (this year) | -7.88% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +14.81% |
| P/E ratio | NM |
| Price/Sales | 7.81 |
| Price/Book | 0.88 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BRKRBruker Corp | +0.36 | +0.53% |
| QGENQiagen NV | +0.18 | +0.37% |
| ---- | ||
| PKIPerkinElmer Inc | -0.33 | -0.24% |
Data as of 1:00pm ET, 11/25/2022
Financials
| Next reporting date | February 9, 2023 |
| EPS forecast (this quarter) | $3.48 |
| Annual revenue (last year) | $2.9B |
| Annual profit (last year) | $4.2B |
| Net profit margin | 145.28% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Hercules, California |
Forecasts
